[go: up one dir, main page]

ATE477019T1 - GLYCYRRHETIC ACID-30 AMIDE DERIVATIVES AND APPLICATIONS THEREOF - Google Patents

GLYCYRRHETIC ACID-30 AMIDE DERIVATIVES AND APPLICATIONS THEREOF

Info

Publication number
ATE477019T1
ATE477019T1 AT06791264T AT06791264T ATE477019T1 AT E477019 T1 ATE477019 T1 AT E477019T1 AT 06791264 T AT06791264 T AT 06791264T AT 06791264 T AT06791264 T AT 06791264T AT E477019 T1 ATE477019 T1 AT E477019T1
Authority
AT
Austria
Prior art keywords
amide derivatives
applications
glycyrrhetic acid
derivatives
cough
Prior art date
Application number
AT06791264T
Other languages
German (de)
Inventor
Jianwu Wang
Weiren Xu
Jianping Yong
Lida Tang
Shijun Zhang
Lijun Liu
Yuli Wang
Xiaowen Ren
Original Assignee
Tianjin Inst Pharm Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Inst Pharm Research filed Critical Tianjin Inst Pharm Research
Application granted granted Critical
Publication of ATE477019T1 publication Critical patent/ATE477019T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to the field of a medicine for treating diseases associated with inflammation, immunity or infection, and in particular, to glycyrrhetinic acid-30-amide derivatives of general formula I and their preparation, and a pharmaceutical composition containing the same. Said derivatives and composition exhibit anti -inflammatory, analgesic, anti-allergic, cough-preventing, liver-protecting and anti-viral properties, wherein each group is as defined in the description.
AT06791264T 2005-10-14 2006-10-16 GLYCYRRHETIC ACID-30 AMIDE DERIVATIVES AND APPLICATIONS THEREOF ATE477019T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2005100153718A CN100488979C (en) 2005-10-14 2005-10-14 Glycyrrhetinic acid-30-acylamide derivatives and its use
PCT/CN2006/002711 WO2007041969A1 (en) 2005-10-14 2006-10-16 Glycyrrhetinic acid-30-amide derivatives and the uses thereof

Publications (1)

Publication Number Publication Date
ATE477019T1 true ATE477019T1 (en) 2010-08-15

Family

ID=37942322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06791264T ATE477019T1 (en) 2005-10-14 2006-10-16 GLYCYRRHETIC ACID-30 AMIDE DERIVATIVES AND APPLICATIONS THEREOF

Country Status (9)

Country Link
US (1) US7790759B2 (en)
EP (1) EP1935892B1 (en)
JP (1) JP5286087B2 (en)
CN (1) CN100488979C (en)
AT (1) ATE477019T1 (en)
AU (1) AU2006301708B2 (en)
DE (1) DE602006016146D1 (en)
ES (1) ES2350053T3 (en)
WO (1) WO2007041969A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101229172B (en) * 2007-12-28 2010-10-27 天津药物研究院 Solid dispersing agent of glycyrrhetinic acid 30-acylamide derivatives, preparing method and uses thereof
WO2009090063A1 (en) * 2008-01-16 2009-07-23 Jado Technologies Gmbh Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
KR101220182B1 (en) 2009-02-25 2013-01-11 에스케이바이오팜 주식회사 Azole derivatives, composition comprising thereof and method for treating parkinson's disease using the compounmd
CN101899081B (en) * 2009-05-31 2012-09-05 江苏正大天晴药业股份有限公司 Synthesis method of glycyrrhetinic acid ester derivatives and deoxyglycyrrhetinic acid ester compound
CN102653550A (en) * 2011-03-01 2012-09-05 广西壮族自治区药用植物园 Preparation and application of glycyrrhetinic acid
CN102250187B (en) * 2011-04-25 2013-03-27 北京中海康医药科技发展有限公司 Glycyrrhetinic acid derivate and preparation method thereof
CN102241726B (en) * 2011-05-27 2013-06-12 苏州大学 Glycyrrhetinic acid derivative and application thereof as antitumor medicament
CN102813661B (en) * 2011-06-09 2014-04-09 天津药物研究院 Application for glycyrrhetinic acid derivatives
TWI424839B (en) 2011-10-27 2014-02-01 Univ Kaohsiung Medical 18β-glycyrrhetinic acid derivatives and its usage thereof
CN103102383A (en) * 2011-11-14 2013-05-15 天津药物研究院 Crystal form A of glycyrrhetinic acid-30-amide derivative and preparation method thereof
CN103102382A (en) * 2011-11-14 2013-05-15 天津药物研究院 Crystal form B of glycyrrhetinic acid-30-amide derivative and preparation method thereof
CN102579462B (en) * 2012-01-18 2013-05-22 苏州大学 Application of Glycyrrhetinic Acid Derivatives in the Preparation of Anti-inflammatory Drugs
CN102838651B (en) * 2012-09-26 2014-05-28 天津药物研究院 Oleanolic acid derivatives, and preparation method and application thereof
TR201902205T4 (en) * 2013-11-25 2019-03-21 Suzumura Akio Glycyrretinic acid derivative and its use.
US9896476B1 (en) 2017-09-21 2018-02-20 King Saud University Glycyrrhetic acid derivatives
CN107619425A (en) * 2017-09-21 2018-01-23 南京师范大学 A kind of tail is connected to aryl ruthenium complex and its synthetic method and the application of machine guide molecule
CN110776549B (en) * 2019-11-25 2021-06-11 烟台大学 Nitrogen heterocyclic ring glycyrrhetinic acid derivative, preparation method thereof and application thereof in resisting influenza A virus
CN111018938B (en) * 2019-12-10 2021-05-25 中国人民解放军第二军医大学 Pentacyclic triterpenoid glycyrrhetinic acid derivative and preparation method and application thereof
CN118561945A (en) * 2024-05-22 2024-08-30 厦门稀土材料研究所 18β-glycyrrhizic acid ester derivatives and preparation method and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1447162A (en) 1974-03-12 1976-08-25 Landerlan Sa Lab Triterpene derivatives
GB1516271A (en) 1976-03-15 1978-06-28 Biorex Laboratories Ltd Glycyrrhetinic acid derivatives
GB2140809A (en) 1983-06-01 1984-12-05 Biorex Laboratories Ltd New derivatives of glycyrrhetinic acid
GB0105772D0 (en) 2001-03-08 2001-04-25 Sterix Ltd Use
DE10307388A1 (en) 2003-02-21 2004-09-02 Cognis Deutschland Gmbh & Co. Kg Glyzyrrhetinsäureester
JP2007521292A (en) * 2003-06-30 2007-08-02 メルク　エンド　カムパニー　インコーポレーテッド 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
CN1257182C (en) * 2004-04-06 2006-05-24 南开大学 The preparation method of glycyrrhetinic acid

Also Published As

Publication number Publication date
CN100488979C (en) 2009-05-20
CN1948332A (en) 2007-04-18
US7790759B2 (en) 2010-09-07
DE602006016146D1 (en) 2010-09-23
JP2009511511A (en) 2009-03-19
EP1935892B1 (en) 2010-08-11
EP1935892A4 (en) 2009-04-01
WO2007041969A1 (en) 2007-04-19
AU2006301708A1 (en) 2007-04-19
ES2350053T3 (en) 2011-01-17
EP1935892A1 (en) 2008-06-25
US20080214636A1 (en) 2008-09-04
JP5286087B2 (en) 2013-09-11
AU2006301708B2 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
ATE477019T1 (en) GLYCYRRHETIC ACID-30 AMIDE DERIVATIVES AND APPLICATIONS THEREOF
BRPI0915064B8 (en) quinoxalinedione derivatives, their uses, and medicines
ATE368066T1 (en) HYDROPHILIC POLYMER DERIVATIVE WITH Y-BRANCH AND PRODUCTION PROCESS THEREOF; MEDICAL COMPOSITE CONTAINING THE ABOVE COMPOUND
BR0214344A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
FR2911138B1 (en) NOVEL N, N'-2,4-DIANILINOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
BR0214342A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
CY1113846T1 (en) PYRIMIDINIS DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF ASTHMA, COPD, ALLERGIKIS RINITIDAS, ALLERGIKIS EPIPEFYKITIDAS, ATOPIKIS DERMATITIDAS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, bacterial infections and DERMATOSIS
ATE455786T1 (en) 6-11 BICYCLIC KETOLIDE DERIVATIVES
BR0312513A (en) Thiophene glycoside derivatives, processes for their production, medicines containing these compounds and their use
BR112014008686A2 (en) oxazine derivatives and their use in the treatment of disease
BRPI0720220B8 (en) quinoline derivative, its pharmaceutical composition, its use, its preparation process, combination and product comprising it
BRPI0815547B8 (en) pharmaceutical composition comprising cyclic depsipeptides, and their uses
BR0315580A (en) Methylene Urea Derivatives
BR112014006763A2 (en) n- (3- (2-amino-6,6-difluoro-4,4a, 5,6,7,7a-hexahydro-cyclopenta [e] [1,3] oxazin-4-yl) -phenyl) -amides as bace1 inhibitors
FR2919869B1 (en) NOVEL N, N'-2,4-DIANILINOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
UA110463C2 (en) PHARMACEUTICAL COMPOSITION OF 4-{[9-CHLORO-7-(2-FLUORO-6-METHOXYPHENYL)-5H-PYRIMIDO[5,4-d][2]BENZAZIPINE-2-YL]AMINO}-2-METHOXT BENZOIC ACID FOR TREATMENT OF CANCER AND OTHER DISEASES AND IMPAIRED HEALTH CONDITIONS
BRPI0411098A (en) benzofuranocarboxamides, with pi3k activity, as therapeutic agents
CY1111442T1 (en) Piperidine compounds and their uses
BRPI0514310A (en) Substituted 8-aminoalkoxy xanthines, method for their production and use as medicines
CL2011001413A1 (en) Compounds derived from 5-amino-2- (1-hydroxyethyl) -tetrahydropyran; pharmaceutical composition comprising one of the compounds; and its use in the preparation of medicaments for the prevention or treatment of a bacterial infection.
CA2692191C (en) Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
BR0310050A (en) Bicyclic ketolide derivatives 6-11, pharmaceutical compositions and processes
UY30363A1 (en) SUBSTITUTED DERIVATIVES OF THE N- (3-OXO-2,3-DIHIDRO-1H-ISOINDOL-4-IL) -1-NAFTAMIDE, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
ATE479433T1 (en) NEW LONG-ACTING BETA-2 AGONISTS AND THEIR USE AS MEDICINAL PRODUCTS
BRPI0411092A (en) benzo [b] thiophenes substituted with 3-arylsulfanyl and 3-heteroarylsulfanyl as therapeutic agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties